Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

6-Hydroxybuspirone Is a Major Active Metabolite of Buspirone: Assessment of Pharmacokinetics and 5-Hydroxytryptamine1A Receptor Occupancy in Rats

Harvey Wong, Randy C. Dockens, Lori Pajor, Suresh Yeola, James E. Grace Jr., Arlene D. Stark, Rebecca A. Taub, Frank D. Yocca, Robert C. Zaczek and Yu-Wen Li
Drug Metabolism and Disposition August 2007, 35 (8) 1387-1392; DOI: https://doi.org/10.1124/dmd.107.015768
Harvey Wong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Randy C. Dockens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lori Pajor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suresh Yeola
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James E. Grace Jr.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arlene D. Stark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca A. Taub
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank D. Yocca
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert C. Zaczek
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yu-Wen Li
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 35 no. 8 1387-1392
DOI 
https://doi.org/10.1124/dmd.107.015768
PubMed 
17494642

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received March 16, 2007
  • Accepted May 8, 2007
  • Published online July 19, 2007.

Article Versions

  • Earlier version (May 9, 2007 - 08:58).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Harvey Wong1,
  2. Randy C. Dockens,
  3. Lori Pajor,
  4. Suresh Yeola,
  5. James E. Grace, Jr.,
  6. Arlene D. Stark,
  7. Rebecca A. Taub2,
  8. Frank D. Yocca3,
  9. Robert C. Zaczek and
  10. Yu-Wen Li
  1. Departments of Metabolism and Pharmacokinetics (H.W., L.P., J.E.G.), Clinical Discovery (R.C.D.), Biotransformation (S.Y.), and Neuroscience Biology (A.D.S., R.A.T., F.D.Y., R.C.Z., Y.W.L.), Pharmaceutical Research Institute, Bristol-Myers Squibb, Wallingford, Connecticut
  1. Address correspondence to:
    Dr. Yu-Wen Li, Neuroscience Biology, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, CT 06492-7660. E-mail: yu-wen.li{at}bms.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to August 2022

AbstractFullPdf
Aug 20171219
Sep 20170217
Oct 201733312
Nov 201743227
Dec 20171158
Jan 20182225
Feb 201812123
Mar 201833122
Apr 201843642
May 201802828
Jun 201802821
Jul 201802635
Aug 201803032
Sep 201801510
Oct 201801815
Nov 201801511
Dec 201840414
Jan 20192305
Feb 201919015
Mar 201919111
Apr 201929113
May 20191926
Jun 201913116
Jul 20192116
Aug 20193015
Oct 20194215
Nov 20193226
Dec 20193839
Jan 202026610
Feb 20202516
Mar 20203234
May 20204604
Jun 20202002
Jul 20201302
Aug 20201503
Sep 20203327
Oct 20203037
Nov 202032412
Dec 20203647
Jan 20212776
Feb 20211923
Mar 20213599
Apr 202125711
May 20214612
Jun 20212279
Jul 20212315
Aug 20211442
Sep 20212211
Oct 20211633
Nov 20212128
Dec 20212821
Jan 20222048
Feb 20224225
Mar 20222817
Apr 20221424
May 20223826
Jun 20222401
Jul 202225110
Aug 20222211

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 35 (8)
Drug Metabolism and Disposition
Vol. 35, Issue 8
1 Aug 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
6-Hydroxybuspirone Is a Major Active Metabolite of Buspirone: Assessment of Pharmacokinetics and 5-Hydroxytryptamine1A Receptor Occupancy in Rats
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

6-Hydroxybuspirone Is a Major Active Metabolite of Buspirone: Assessment of Pharmacokinetics and 5-Hydroxytryptamine1A Receptor Occupancy in Rats

Harvey Wong, Randy C. Dockens, Lori Pajor, Suresh Yeola, James E. Grace, Arlene D. Stark, Rebecca A. Taub, Frank D. Yocca, Robert C. Zaczek and Yu-Wen Li
Drug Metabolism and Disposition August 1, 2007, 35 (8) 1387-1392; DOI: https://doi.org/10.1124/dmd.107.015768

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

6-Hydroxybuspirone Is a Major Active Metabolite of Buspirone: Assessment of Pharmacokinetics and 5-Hydroxytryptamine1A Receptor Occupancy in Rats

Harvey Wong, Randy C. Dockens, Lori Pajor, Suresh Yeola, James E. Grace, Arlene D. Stark, Rebecca A. Taub, Frank D. Yocca, Robert C. Zaczek and Yu-Wen Li
Drug Metabolism and Disposition August 1, 2007, 35 (8) 1387-1392; DOI: https://doi.org/10.1124/dmd.107.015768
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Human ADME Properties of Abrocitinib
  • MSCs Pharmacokinetics under liver diseases
  • In Vitro P450 Suppression by Peptide Not Observed in Clinic
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics